Guggenheim Capital LLC decreased its position in The Beauty Health Company (NASDAQ:SKIN – Get Rating) by 7.0% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 38,451 shares of the company’s stock after selling 2,891 shares during the period. Guggenheim Capital LLC’s holdings in Beauty Health were worth $453,000 as of its most recent SEC filing.
A number of other hedge funds have also modified their holdings of the stock. MetLife Investment Management LLC lifted its holdings in Beauty Health by 3.1% during the third quarter. MetLife Investment Management LLC now owns 53,638 shares of the company’s stock worth $632,000 after acquiring an additional 1,596 shares in the last quarter. Nisa Investment Advisors LLC increased its position in shares of Beauty Health by 88.9% in the third quarter. Nisa Investment Advisors LLC now owns 4,490 shares of the company’s stock valued at $52,000 after acquiring an additional 2,113 shares during the last quarter. Axiom Investors LLC DE increased its position in Beauty Health by 1.4% during the third quarter. Axiom Investors LLC DE now owns 163,572 shares of the company’s stock worth $1,929,000 after buying an additional 2,205 shares during the last quarter. Jennison Associates LLC increased its position in Beauty Health by 8.0% during the third quarter. Jennison Associates LLC now owns 37,151 shares of the company’s stock worth $438,000 after buying an additional 2,754 shares during the last quarter. Finally, New York State Common Retirement Fund increased its position in Beauty Health by 2.1% during the third quarter. New York State Common Retirement Fund now owns 143,224 shares of the company’s stock worth $1,689,000 after buying an additional 2,894 shares during the last quarter. 78.37% of the stock is owned by institutional investors and hedge funds.
Beauty Health Price Performance
SKIN stock opened at $11.16 on Friday. The Beauty Health Company has a 12-month low of $8.25 and a 12-month high of $19.38. The company has a current ratio of 10.79, a quick ratio of 9.20 and a debt-to-equity ratio of 4.28. The firm’s 50-day moving average price is $11.43 and its two-hundred day moving average price is $11.18. The stock has a market capitalization of $1.48 billion, a price-to-earnings ratio of -62.00 and a beta of 1.16.
Wall Street Analyst Weigh In
Beauty Health Company Profile
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
- Get a free copy of the StockNews.com research report on Beauty Health (SKIN)
- What the SVB Financial Collapse Means for U.S. Banks
- MarketBeat Week in Review – 3/6 – 3/10
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.